• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
72,696.39 -1,836.57
( -2.46%)
Global Indices
Nasdaq
45,612.20 -430.24
(-0.93%)
Dow Jones
6,526.68 -100.81
(-1.52%)
Hang Seng
51,583.72 -1,788.81
(-3.35%)
Nikkei 225
9,923.24 4.91
(0.05%)
Forex
USD-INR
93.13 0.41
(0.44%)
EUR-INR
107.17 0.41
(0.39%)
GBP-INR
124.14 0.56
(0.45%)
JPY-INR
0.59 0.00
(0.73%)

EQUITY - MARKET SCREENER

Nephro Care India Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
92991
INE0SUN01013
32.4415882
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEPHROCARE
36.52
104.77
EPS(TTM)
Face Value()
Div & Yield %
1.74
10
0
 

agi greenpac ltd
Hindustan Organic Chemicals halts operations at Kochi phenol complex amid LPG supply disruption
Mar 10,2026

The disruption follows a government directive requiring public sector oil companies to prioritise LPG supply for domestic consumers, which has triggered a force majeure under the existing bulk LPG supply arrangement.

HOCL stated that its available LPG buffer stock will be exhausted by 09 March 2026.

As a result, the company has reduced production at the phenol and cumene plants and temporarily shut down the PRU unit from March 9. Other downstream units may also be shut within two days if supply disruptions persist. The hydrogen peroxide plant will continue operating.

The announcement was made post trading hours yesterday.

Hindustan Organic Chemicals (HOCL) is engaged in the manufacturing of of phenol, acetone, and hydrogen peroxide. The company provides the basic organic chemicals essential for vital industries like resins and laminates, dyes and dyes intermediates, drugs and pharmaceuticals, rubber chemicals, paints, pesticides and others. It also produces the versatile engineering plastic polytetrafluoroethylene (PTFE) through its subsidiary.

The company had reported a consolidated net loss of Rs 3.92 crore in the quarter ended December 2025 as against net loss of Rs 78.99 crore during the previous quarter ended December 2024. Sales declined 10.85% to Rs 147.24 crore in Q3 FY26 as compared with Q3 FY25.

The scrip rose 0.31% to currently trade at Rs 29.10 on the BSE.